{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:45:25Z","timestamp":1787661925978,"version":"build-2736575974"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1097\/ppo.0000000000000040","type":"journal-article","created":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T10:48:44Z","timestamp":1395744524000},"page":"160-165","source":"Crossref","is-referenced-by-count":30,"title":["Novel Approaches to Enhance the Specificity and Safety of Engineered T Cells"],"prefix":"10.1097","volume":"20","author":[{"given":"Victor D.","family":"Fedorov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Sadelain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Kloss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210203","first-page":"1432","article-title":"Breakthrough of the year 2013. Cancer immunotherapy.","volume":"342","year":"2013","journal-title":"Science"},{"key":"R15-13-20210203","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2008-02-078071","article-title":"B lymphocytes: how they develop and function.","volume":"112","year":"2008","journal-title":"Blood"},{"key":"R25-13-20210203","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1056\/NEJMe1109971","article-title":"Eliminating cells gone astray.","volume":"365","year":"2011","journal-title":"N Engl J Med"},{"key":"R26-13-20210203","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/mt.2011.273","article-title":"Live and let die: a new suicide gene therapy moves to the clinic.","volume":"20","year":"2012","journal-title":"Mol Ther"},{"key":"R27-13-20210203","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nbt.2471","article-title":"Double or nothing on cancer immunotherapy.","volume":"31","year":"2013","journal-title":"Nat Biotechnol"},{"key":"R33-13-20210203","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/nbt.2725","article-title":"Reassessing target antigens for adoptive T-cell therapy.","volume":"31","year":"2013","journal-title":"Nat Biotechnol"},{"key":"R36-13-20210203","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy.","volume":"12","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"R43-13-20210203","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nri3405","article-title":"Molecular mechanisms of T cell co-stimulation and co-inhibition.","volume":"13","year":"2013","journal-title":"Nat Rev Immunol"}],"container-title":["The Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PPO.0000000000000040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:20:37Z","timestamp":1620969637000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130404-201403000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/ppo.0000000000000040","relation":{},"ISSN":["1528-9117"],"issn-type":[{"value":"1528-9117","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}